Showing results (341-350 of 354) with videos related to
Sort By:
Pageof 36
Cell Death and Differentiation|January 17, 2015
Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growthS Adi Harel, N Bossel Ben-Moshe, Y Aylon, et al.Cell Death and Differentiation|August 7, 2010
Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cellsI Kogan-Sakin, Y Tabach, Y Buganim, et al.American Heart Journal|December 15, 2010
Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failureKirkwood F Adams, Mandeep R Mehra, Ron M Oren, et al.Journal of Cardiac Failure|March 9, 2010
Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failureLarry A Allen, G Michael Felker, Mandeep R Mehra, et al.Circulation|August 18, 2004
Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure)Lynne Warner Stevenson, Leslie W Miller, Patrice Desvigne-Nickens, et al.Oncogene|June 20, 1996
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cellsS S Bacus, Y Yarden, M Oren, et al.American Heart Journal|December 5, 2009
Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failureKirkwood F Adams, Ileana L Piña, Jalal K Ghali, et al.American Heart Journal|April 21, 2009
Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) RegistryKirkwood F Adams, James H Patterson, John H Patterson, et al.Leukemia|May 15, 2015
p53-dependent non-coding RNA networks in chronic lymphocytic leukemiaC J Blume, A Hotz-Wagenblatt, J Hüllein, et al.American Heart Journal|May 4, 2010
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) programChristopher M O'Connor, Alan B Miller, John E A Blair, et al.Pageof 36